FFFMX | JVLIX | FFFMX / JVLIX | |
Total Expense Ratio | 0.32 | 0.71 | 45% |
Annual Report Gross Expense Ratio | 0.32 | 0.72 | 44% |
Fund Existence | 5 years | 28 years | - |
Gain YTD | 6.280 | 4.633 | 136% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 107B | 17.5B | 611% |
Annual Yield % from dividends | 1.85 | 0.98 | 188% |
Returns for 1 year | 9.35 | -2.07 | -451% |
Returns for 3 years | 30.81 | 13.21 | 233% |
Returns for 5 years | N/A | 42.58 | - |
Returns for 10 years | N/A | 29.42 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
REK | 16.95 | 0.14 | +0.83% |
ProShares Short Real Estate | |||
FIBR | 87.66 | -0.15 | -0.18% |
iShares U.S. Fixed Inc Bal Rsk Sysmc ETF | |||
NEA | 10.82 | -0.08 | -0.71% |
Nuveen AMT-Free Quality Municipal Income Fund | |||
AOK | 38.37 | -0.32 | -0.83% |
iShares Core 30/70 Cnsrv Allc ETF | |||
PBE | 63.94 | -0.80 | -1.24% |
Invesco Biotechnology & Genome ETF |